US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 20, 2020 (7 years ago)

Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.

What was recalled

Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22.

Recalling firm
Teva Pharmaceuticals USA
NDC code
0591-2245-22
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0862-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Mesalamine recalls

See all